Innovation Pharmaceuticals Plans for Phase 2 Trial of New Treatment for Ulcerative Colitis

NEXT STORY
PDS Biotechnology Expands Patent Portfolio for its Novel Versamune® Platform
PREV STORY
Zai Lab to Announce Financial Results for the Full Year Ended December 31, 2019 and Corporate Updates on March 19, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biomedical Refrigerators and Freezers Market Value to Reach US$4.28 billion by the End of 2024: Transparency Market Research

Albany – NY, Dec. 15, 2017 (GLOBE NEWSWIRE) -- The global biomedical refrigerators and ...

author_avatar
NASDAQ Market News

Cellectar Biosciences Enters into Strategic Collaboration with Onconova Therapeutics to Develop New Phospholipid Drug Conjugates

MADISON, Wis., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, ...

author_avatar
NASDAQ Market News

MDxHealth Provides Business Update for the first nine months of 2018

NEWS RELEASE   REGULATED INFORMATION INTERIM TRADING UPDATE Product and Service revenue up 29% year-on-year IRVINE, ...

author_avatar
NASDAQ Market News